James M. Mock - Dec 5, 2024 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Financial Officer
Signature
/s/ Brian Sandstrom, As Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Dec 5, 2024
Transactions value $
$0
Form type
4
Date filed
12/6/2024, 04:55 PM
Previous filing
Dec 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Restricted Stock Units Award $0 +189K $0.00 189K Dec 5, 2024 Common Stock 189K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this restricted stock unit award will vest on December 5, 2025, with the remainder vesting in twelve (12) equal quarterly installments thereafter.